Cholera vaccine live(Johnson & Johnson/Emergent BioSolutions)

活霍乱疫苗（强生/PaxVax）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameCholera vaccine live(Johnson & Johnson/Emergent BioSolutions)
Drug Alias NameCholera vaccine live attenuated - PaxVaxCholera vaccine CVD 103-HgRCVD HgR 103 vaccineOrochol-BernaMutacol-Berna +[11] 
ClassificationVaccines > Development/production technology > Live attenuated vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCholera
Global Approved IndicationsCholera
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2016/06/10
Country/TerritoryUnited StatesAustraliaMali +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesJohnson & Johnson
China Registration ClassN/A

Develop Information

Active CompaniesEmergent Netherlands Bv
Inactive CompaniesEmergent Biosolutions IncUniversity Of Maryland, BaltimoreEmory University +[4] 
Active IndicationsCholera
Inactive IndicationsN/A

Other Information

ATC CodeJ07AE02
Related LinksN/A